Efficacy and safety of novel carbapenem–β-lactamase inhibitor combinations: Results from phase II and III trials
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2022.925662
Abstract: Objectives The addition of novel β-lactamase inhibitors to carbapenems restores the activity against multidrug-resistant Gram-negative bacteria. The aim of this study was to summarize the evidence on the efficacy and safety of novel carbapenem–β-lactamase inhibitor… read more here.
Keywords: novel carbapenem; lactamase inhibitor; carbapenem lactamase; inhibitor combinations ... See more keywords